Thursday, 10 October 2013
Deal Alert: Aarin, Accel, IDG & Kitven invest Rs.27.5 Cr in biopharma co Theramyt
Posted on 21:22 by Unknown
Aarin Capital, Accel Partners, IDG Ventures as well as Karnataka state government-backed KITVEN have invested INR 27.5 crore in Bangalore-based biopharma company Theramyt Novobiologics. Theramyt is developing therapies for cancer, rheumatoid arthritis and diabetes and will use the funding on research and development, hiring talent and infrastructure.
Theramyt is the second venture for
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment